Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Beyond Histology: A Unified Transcriptomic Atlas Defines Lung Cancer Biologic States and Subtypes.

bioRxiv : the preprint server for biology·2026
Same author

Tolerance and Resistance to Targeted Therapy in NSCLC: Emerging Concepts and Strategies.

JTO clinical and research reports·2026
Same author

A multiplex, prime editing framework for identifying drug resistance variants at scale.

Cell genomics·2026
Same author

Author Correction: Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion.

Nature genetics·2026
Same author

New insights in regulation of RAS isoforms revealed by protein structures.

Trends in biochemical sciences·2025
Same author

Osimertinib retreatment for patients with advanced EGFR-mutated non-small cell lung cancer.

Cancer treatment and research communications·2025

関連する実験動画

Updated: May 11, 2026

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
07:49

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

腫瘍抑制のための連続モデル.

Alice H Berger1, Alfred G Knudson, Pier Paolo Pandolfi

  • 1Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Harvard Medical School, Boston, Massachusetts 02115, USA.

Nature
|August 12, 2011
PubMed
まとめ
この要約は機械生成です。

網膜母細胞腫の研究は,腫瘍発生にはいくつかの突然変異が必要であることを示しています. 新しい連続体モデルは,部分腫瘍抑制遺伝子 (TSG) の不活性化が癌を駆動する方法を説明しています.

さらに関連する動画

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
09:52

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication

Published on: September 20, 2016

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle
12:19

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle

Published on: June 7, 2024

関連する実験動画

Last Updated: May 11, 2026

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
07:49

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
09:52

A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication

Published on: September 20, 2016

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle
12:19

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle

Published on: June 7, 2024

科学分野:

  • 腫瘍学 腫瘍学
  • 遺伝学 遺伝学とは
  • 癌生物学 癌生物学について

背景:

  • 40年前,網膜芽細胞腫の統計分析により,腫瘍形成はたった2つの変異から始まることが明らかになった.
  • これは,遺伝性癌症症候群における腫瘍抑制遺伝子 (TSG) を説明する2つのヒット仮説につながった.
  • 現在の理解では,部分的なTSG不活性化でさえも,がんの発症に大きく寄与することを示しています.

研究 の 目的:

  • 腫瘍発生における部分腫瘍抑制遺伝子不活性化に関する証拠を分析する.
  • 腫瘍抑制遺伝子 (TSG) 機能のための新しい連続体モデルを提案する.
  • ガンで観察されたTSG変異の多様な範囲を説明するために.

主な方法:

  • 文献レビューと,腫瘍抑制遺伝子機能に関する既存の証拠の分析.
  • 現在の研究成果に基づいた理論的連続体モデルの開発.
  • 既定の仮説に対する提案されたモデルの比較分析.

主要な成果:

  • TSGの部分的無活性化が腫瘍発生の重要な要因であることを証拠が支持しています.
  • 提案された連続体モデルは,TSGの不活性化度合いを含む.
  • このモデルは,伝統的な2つのヒット仮説と比較して,がんにおけるTSG変異のスペクトルについてより包括的な説明を提供します.

結論:

  • 腫瘍発生は,腫瘍抑制遺伝子の不活性化度によって影響される複雑なプロセスです.
  • TSG機能の連続体モデルは,がんの発症を理解するためのより良い枠組みを提供します.
  • さらなる研究は,様々な癌のタイプにおける連続体モデルを検証し,精錬するために必要である.